What patients with IPF can expect concerning symptoms and quality of life during first six months of antifibrotic treatment?
D. Jastrzebski (Zabrze, Poland), A. Gasiorek (Zabrze, Poland), D. Galczynska (Zabrze, Poland), S. Czyz (Zabrze, Poland), B. Ziaja (Zabrze, Poland), J. Warzecha (Zabrze, Poland), S. Kostorz-Nosal (Zabrze, Poland), D. Ziora (Zabrze, Poland)
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Jastrzebski (Zabrze, Poland), A. Gasiorek (Zabrze, Poland), D. Galczynska (Zabrze, Poland), S. Czyz (Zabrze, Poland), B. Ziaja (Zabrze, Poland), J. Warzecha (Zabrze, Poland), S. Kostorz-Nosal (Zabrze, Poland), D. Ziora (Zabrze, Poland). What patients with IPF can expect concerning symptoms and quality of life during first six months of antifibrotic treatment?. 1343
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The influence of fenspiride in complex therapy on quality of life in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010
The effect of individual and group education on disease symptoms, pulmonary functions and quality of life in asthma patient Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002
Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year Source: Eur Respir J 2010; 35: 1022-1030 Year: 2010
An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020
What predicts quality of life in elderly patients with COPD? Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009
NIPPV‘s influence in severe COPD patients health-related quality of life Source: Eur Respir J 2006; 28: Suppl. 50, 186s Year: 2006
Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001
Patients’ expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis. Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018
Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ? Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
How does patient‘s quality of life guide their preferences regarding asthma therapy? Source: Annual Congress 2006 - Respiratory disease managment in primary care Year: 2006
The quality of life evaluation and survival study (QuESS): comorbidities in patients with chronic respiratory failure do not influence status as measured by quality of life questionnaires Source: Eur Respir J 2001; 18: Suppl. 33, 54s Year: 2001
Does rehabilitation improve health-related quality of life (HRQL) in patients with advanced respiratory failure? Source: Annual Congress 2007 - Health-related quality of life (HRQL) in patients with severe chronic respiratory failure Year: 2007
The improvement in quality of life in patients with COPD: the influence of long-term regular monitoring and good compliance Source: Eur Respir J 2003; 22: Suppl. 45, 242s Year: 2003
Group therapy as a technique to improve quality of life in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 843s Year: 2006
What influences change in health status in COPD in a seven year follow-up? Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015
Adapted physical activity intervention for improvement of quality of life in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020
Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis Source: ERJ Open Res, 7 (1) 00107-2020; 10.1183/23120541.00107-2020 Year: 2021
Quality of life and symptoms improvement after 6 months treatment with roflumilast 500 μg daily in a large Greek COPD cohort Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013
The effect of sleep-related intervention on the quality of life in pulmonary patients Source: Eur Respir J 2001; 18: Suppl. 33, 420s Year: 2001
The effect of community lung rehabilitation guidance on the quality of life of patients with COPD. Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018